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Original article
The prevention of heart failure (HF) is an important public 
health goal, because HF has high prevalence, morbidity, 
mortality, and associated cost of care.1–3 Early identifica-
tion and aggressive management of patients at high risk of 
developing HF have been strongly recommended and may 
be of particular importance in the elderly patients, who 
are at highest risk of developing HF.4,5 Hypertension is one 
of the most common precursors of HF, and elevated blood 
pressure (BP) is an important and modifiable risk factor 
for its development.6,7 Ambulatory BP monitoring pro-
vides information that cannot be obtained from office BP 
measurements, such as nighttime and daytime mean val-
ues and circadian variability. Several epidemiological and 
clinical studies have demonstrated that ambulatory BP is a 
better predictor of adverse cardiovascular outcomes than 
office BP.8,9
Left ventricular (LV) global longitudinal strain (GLS) is an 
echocardiographic measure of LV systolic function and an 
indicator of early subclinical cardiac dysfunction, even when 
LV ejection fraction (LVEF) is in the normal range. Moreover, 
several studies have reported that GLS is a prognostic indi-
cator for mortality, cardiovascular events, and HF develop-
ment, independent of LVEF.10–12 Recently, Ye et al. reported 
that higher pulsatile arterial load, and especially proximal 
arterial stiffness, was associated with impaired GLS, and that 
BP measures failed to show an independent association with 
GLS; however, ambulatory BP measures were not tested in 
that study.13 Previous studies reported that ambulatory BP 
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BACKGROUND
Left ventricular (LV) global longitudinal strain (GLS) is an early indicator 
of subclinical cardiac dysfunction, even when LV ejection fraction (LVEF) 
is normal, and is an independent predictor of cardiovascular events. 
Ambulatory blood pressure (BP) is a better predictor of cardiovascular 
events, including heart failure, than office BP. We investigated the asso-
ciation of office and ambulatory BP measurements with subclinical LV 
systolic dysfunction in a community-based cohort with normal LVEF.
METHODS
Two-dimensional speckle-tracking echocardiography and 24-hour 
ambulatory BP monitoring were performed in 577 participants (mean 
age 70 ± 9 years; 60% women) with LVEF ≥50% from the Cardiovascular 
Abnormalities and Brain Lesions (CABL) study. Univariable and multi-
variable linear regression analyses were used to assess the associations 
of BP measures with GLS.
RESULTS
Higher ambulatory and office BP values were consistently associated 
with impaired GLS. After adjustment for pertinent covariates (age, sex, 
race/ethnicity, body mass index, diabetes mellitus, coronary artery dis-
ease, LV mass index, and antihypertensive medication), office diastolic 
BP and ambulatory systolic and diastolic BPs (24-hour, daytime and 
nighttime) were independently associated with GLS (P = 0.003 for office 
DBP, P ≤ 0.001 for all ambulatory BPs). When ambulatory and office BP 
values were included in the same model, all ambulatory BP measures 
remained significantly associated with GLS (all P < 0.01), whereas office 
BP values were not.
CONCLUSIONS
Ambulatory BP values are significantly associated with impaired 
GLS and the association is stronger than for office BP. Ambulatory BP 
monitoring might have a role in the risk stratification of hypertensive 
patients for early LV dysfunction.
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was more closely associated with echocardiographic param-
eters of LV hypertrophy and LV filling than office BP.14,15 
However, the association of ambulatory BP with subclini-
cal LV systolic dysfunction detected by GLS has not been 
extensively studied. Furthermore, it is not known whether 
ambulatory BP measurements are more closely associated 
with LV subclinical dysfunction than office BP, and could 
therefore be used to as a predictor of LV subclinical dysfunc-
tion in hypertensive patients. Therefore, we investigated the 
association of office and ambulatory BP measurements with 




The study cohort was derived from the Cardiovascular 
Abnormalities and Brain Lesions (CABL) study, whose par-
ticipants were drawn from the Northern Manhattan Study 
(NOMAS). NOMAS is a population-based study designed 
to evaluate the incidence, risk factors, and clinical outcome 
of stroke in the population of northern Manhattan. Study 
design and the methodologies of NOMAS have previously 
been described in detail.16 Briefly, subjects were eligible if 
they (i) had never been diagnosed with a stroke, (ii) were 
≥40  years of age, and (iii) resided for at least 3  months 
in a household with a telephone in northern Manhattan. 
Beginning in September 2005, NOMAS subjects older 
than 50  years who voluntarily agreed to undergo a brain 
magnetic resonance imaging study and more extensive 
cardiovascular assessments were included in the CABL 
study, which was designed to investigate the relationship 
between subclinical cardiovascular disease and subclinical 
brain disease. Participants in CABL who had a complete 
dataset of 24-hour ambulatory BP monitoring and speckle-
tracking strain imaging constitute the cohort of the present 
report. Subjects with LVEF <50% were excluded from the 
analysis.
The study was approved by the institutional review boards 
of Columbia University Medical Center and the University 
of Miami. Written informed consent was obtained from all 
study participants.
Risk factor assessment
Cardiovascular risk factors were ascertained through 
direct examination and interview by trained research 
assistants. Diabetes mellitus was defined by the patient’s 
self-report, current use of insulin or hypoglycemic agents, 
or a fasting blood glucose ≥126 mg/dl on ≥2 occasions. 
Hypercholesterolemia was defined as total serum cholesterol 
>240 mg/dl, a patient’s self-report of hypercholesterolemia 
or the use of lipid-lowering medication. Smoking status 
was defined as self-reported cigarette smoking at any time 
in the past or present. Body mass index was calculated as: 
weight/(height)2 and expressed in kg/m2. Coronary artery 
disease was defined as a history of myocardial infarction, 
coronary artery bypass grafting, or percutaneous coronary 
intervention.
Assessment of office BP and 24-hour ambulatory BP
Office systolic BP (SBP) and diastolic BP (DBP) were 
measured on the nondominant arm in a sitting position 
after 5 minutes of rest, using a mercury sphygmomanome-
ter and an appropriate size arm cuff. Two BP measurements 
obtained after an interval of 5 minutes during the same 
visit were performed and averaged. Ambulatory BP moni-
toring was performed with an appropriately sized BP cuff 
on the nondominant arm, using a BP monitor (SpaceLabs 
Model 90207; Snoqualmie, WA) previously validated by 
the British Hypertension Society Protocol17 and calibrated 
against a reference mercury sphygmomanometer. The 
methods of ambulatory BP monitoring have been previ-
ously published.18 Briefly, the participants were asked to 
follow their usual routine and to note their activities at the 
time of each BP reading in a diary, as well as their sleep 
onset and wake-up times. A BP reading was automatically 
taken and recorded every 15 minutes during waking hours 
and every 30 minutes during sleeping hours for 24 hours. 
The mean SBP and DBP were calculated for the 24-hour 
period and separately for daytime (awake) and nighttime 
(sleep) periods, defined by subjects’ diary reports of actual 
asleep and awake times. BP variability was defined as the 
SDs of mean BP, and calculated separately for daytime and 
nighttime. Night-to-day-ratios (nighttime BP/daytime BP) 
for SBP and DBP were also calculated. Non-dipping pattern 
was defined as SBP night-to-day ratio >0.9.
Echocardiographic assessment
Two-dimensional echocardiography. Transthoracic 
echocardiography was performed by trained registered 
sonographers, following a standardized protocol with a 
commercially available system (iE 33; Philips, Andover, 
MA). Interventricular septum and posterior wall thick-
ness, LV end-diastolic and end-systolic diameters were 
measured from a parasternal long-axis view accord-
ing to the recommendations of the American Society 
of Echocardiography.19 LVEF was calculated using the 
biplane modified Simpson’s rule. LV mass was calculated 
using the Devereux formula20 and indexed by body sur-
face area (LVMI).
Peak velocities of the early phase (E) of the mitral inflow 
were obtained by pulsed-wave Doppler at the mitral valve 
leaflet tips from an apical 4-chamber view. LV myocardial 
velocities by tissue Doppler imaging were obtained at the lat-
eral and septal mitral valve annulus. The peak early diastolic 
(e′) velocity was measured and the E/e′ ratio was calculated 
as an index of LV filling pressure.
Speckle-tracking GLS imaging. Speckle-tracking analy-
sis was performed off-line using commercially available soft-
ware (QLAB Advanced Quantification Software version 8.1, 
Philips). GLS was calculated from the apical 4-chamber and 
2-chamber views as previously described.12,21 At least 2 car-
diac cycles were recorded at a frame rate ≥45 fps, and were 
averaged for GLS analysis. Reproducibility of speckle-track-
ing measurements has been reported previously.22
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Statistical analysis
Data are presented as mean ± SD for continuous variables 
and as proportions for categorical variables. Univariable lin-
ear regression analysis was used to assess the association of 
each BP measure with LVMI, E/e′ and GLS. Multivariable 
linear regression analysis was performed separately for each 
ambulatory and office BP measure to assess their independ-
ent association with the echocardiographic parameters after 
adjustment for pertinent covariates, which were selected 
based on their bivariate association with each echocardio-
graphic parameter (the threshold for inclusion in the mul-
tivariable models was set at a P value of <0.2). To examine 
whether ambulatory BP measures are more closely associ-
ated with the echocardiographic parameters than office BP, 
corresponding ambulatory and office BP variables were 
included in the same regression model. A P value of <0.05 
was considered statistically significant. Statistical analyses 




Of the 1,004 subjects enrolled in CABL, 835 had ambu-
latory BP monitoring performed. Of these, 604 had 
diagnostically adequate speckle-tracking GLS imaging avail-
able. Among those, 27 participants with LVEF <50% were 
excluded. Therefore, the final sample size of the present study 
consisted of 577 participants. The clinical and demographic 
characteristics of the study population are shown in Table 1. 
Almost 70% of the participants were taking antihypertensive 
medications.
Table 2 shows the association of LVMI, E/e′ and GLS with 
demographics, risk factors and echocardiographic variables. 
Impaired (i.e., less negative) GLS was significantly associated 
with older age, diabetes mellitus, coronary artery disease, 
greater LV mass index (all P < 0.01), and antihypertensive 
medication use (P < 0.05).
Association of BP measures with GLS
The association of various BP measurements with echo-
cardiographic parameters (LVMI, E/e′ and GLS) is sum-
marized in Table 3. In univariate linear regression analyses 
examining each predictor in separately, all office BP and 
ambulatory BP measures showed significant association 
with GLS, except the night-to-day ratios, nighttime DBP 
variability, and non-dipping pattern. Similarly, LVMI 
showed a significant association with office and ambula-
tory BP values, except for office DBP. E/e′ showed a signifi-
cant association with BP night-to-day ratios and daytime 
DBP as well as with office and ambulatory SBP and SBP 
variability. Higher BP, both from office and ambulatory 
measurements, and greater BP variability were consistently 
associated with greater LVMI and impaired GLS. Higher 
night-to-day ratios, non-dipping pattern, and lower day-
time DBP were significantly associated with higher E/e′. 
After adjustment (for age, sex, race/ethnicity, body mass 
index, diabetes mellitus, coronary artery disease, LV mass 
index, and antihypertensive medication use), office DBP 
and ambulatory 24-hour, daytime, and nighttime SBP and 
DBP remained significantly associated with GLS, whereas 
office SBP was no longer associated. Greater variability in 
nighttime SBP and daytime DBP also remained signifi-
cantly associated with impaired GLS; however, neither var-
iable remained independently associated with GLS when 
the corresponding average ambulatory BP value (nighttime 
SBP and daytime DBP) was simultaneously included in the 
regression model. After adjustment for relevant covari-
ates, both ambulatory SBP and DBP remained significantly 
associated with LVMI, unlike office SBP and DBP. E/e′ was 
only associated with ambulatory 24-hour, daytime and 
nighttime SBP. Night-to-day ratios and non-dipping pat-
tern were no longer associated with E/e′ in the multivari-
able analysis.
Table 1. Characteristics of the study population
N = 577
Age, years 70.2 ± 9.1
Male 229 (39.7)
Race/ethnicity
 White 74 (12.8)
 Black 96 (16.6)
 Hispanic 398 (69.0)
 Other 9 (1.6)
Body mass index, kg/m2 27.8 ± 4.5
Antihypertensive medication use 394 (68.3)
Diabetes mellitus 166 (28.8)
Hypercholesterolemia 381 (66.0)
Smoking history 306 (53.0)
Coronary artery disease 34 (5.9)
Echocardiographic data
 LV septal thickness, mm 11.3 ± 1.7
 LV end-diastolic dimension, mm 44.4 ± 4.2
 LV posterior wall thickness, mm 11.0 ± 1.5
 LV mass index, g/m2 100.6 ± 23.7
 LVEF, % 64.4 ± 4.9
 E/e′ 9.93 ± 4.25
 GLS, % −17.3 ± 3.0
Office and ambulatory BP values
 Office SBP, mm Hg 134.8 ± 16.6
 Office DBP, mm Hg 78.5 ± 9.2
 24-hour SBP, mm Hg 124.6 ± 14.1
 24-hour DBP, mm Hg 71.4 ± 8.3
Values are shown as mean ± SD or n (%).
Abbreviations: LV, left ventricular; EF, ejection fraction; GLS, 
global longitudinal strain; E, early diastolic mitral inflow velocity; 
e′, early diastolic mitral annular tissue velocity; BP, blood pressure; 
SBP, systolic blood pressure; DBP, diastolic blood pressure.
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Relationship of GLS to ambulatory BP and office BP
When ambulatory SBP and office SBP, or ambulatory 
DBP and office DBP, were entered in the same multivariable 
model, both ambulatory SBP and DBP remained signifi-
cantly associated with GLS in any of the 24-hour, daytime, 
and nighttime periods, whereas office SBP and DBP no 
longer showed a significant association with GLS (Table 4). 
The significant association of ambulatory SBP and DBP with 
LVMI remained even after an additional adjustment for each 
corresponding office BP value (Table  4). Ambulatory SBP 
(24-hour, daytime, and nighttime) remained significantly 
associated with E/e′.
DISCUSSION
In this community-based, predominantly elderly cohort, 
we demonstrated that (i) office DBP and ambulatory SBP 
and DBP in any of the 24-hour, daytime, and nighttime peri-
ods were significantly associated with GLS independently 
of cardiovascular risk factors; (ii) ambulatory SBP and DBP, 
but not office BP, were significantly associated with LVMI, 
whereas only ambulatory SBP was associated with E/e′ after 
adjustment for demographics and potential confounders; 
and (iii) ambulatory BP contributed more to explaining the 
variance of GLS as well as LVMI and E/e′ than office BP.
Previous studies have reported that ambulatory BP was 
more closely associated with echocardiographic parameters 
of LV hypertrophy and LV filling pressure than office BP, a 
circumstance that is in accordance with our findings.14,15,23 
Several clinical studies in selected populations with lit-
tle concomitant disease previously reported that systolic 
longitudinal strain derived from two-dimensional speckle-
tracking echocardiography was significantly impaired in 
hypertensive subjects, as well as in subjects with high-nor-
mal BP, compared with normotensive control subjects.24–26 
However, 1 study reported that significantly impaired GLS 
was observed only in hypertensive patients with extreme LV 
hypertrophic remodeling (LV mass >190 g).27 In the present 
study, we demonstrate in a larger sample a significant asso-
ciation between higher BP values, except for office SBP, and 
impaired GLS even after adjustment for possible confound-
ers, including diabetes mellitus, coronary artery disease, and 
LVMI. Furthermore, we demonstrate for the first time that 
ambulatory BP values are more closely associated with GLS 
than office BP measurements. Higher ambulatory BP was 
significantly associated with impaired GLS after adjustment 
for pertinent covariates and also for office BP, whereas office 
BP was no longer associated with GLS after adjustments for 
covariates. Ambulatory BP monitoring allows multiple BP 
measurements outside of the hospital, which are free from 
observer bias and white coat effect, and provides more 
reproducible information than office BP measurements.28,29 
In fact, marked discrepancies have been documented 
between office and ambulatory BP measurements.30 From 
our results, ambulatory BP monitoring appears to be of value 
for the identification of subjects at risk of subclinical LV 
systolic dysfunction, who are at risk of adverse events.10–12 
Our findings are consistent with previous studies, in which 
target organ damage and adverse cardiovascular outcomes 
were more strongly associated with ambulatory BP than with 
office BP.8,9,31,32
Hypertension is a major risk factor for HF, not only 
because it increases the risk of coronary artery disease, but 
Table 2. Factors associated with LV mass index, E/e′ and GLS
LV mass index E/e′ GLS
B (SE) P value B (SE) P value B (SE) P value
Age (per year) 0.41 (0.11) <0.01 0.10 (0.01) <0.01 0.05 (0.01) <0.01
Male 5.30 (2.00) 0.01 −0.87 (0.24) <0.01 0.45 (0.25) 0.07
Race/ethnicity 0.11 0.01 0.07
 White Reference Reference Reference
 Black −6.39 (3.65) 0.08 1.37 (0.44) <0.01 0.67 (0.46) 0.15
 Hispanic −1.20 (2.99) 0.69 0.73 (0.36) 0.04 −0.11 (0.38) 0.77
 Other −12.7 (8.33) 0.13 −0.33 (0.99) 0.74 −0.35 (1.05) 0.74
Body mass index (per kg/m2) 0.06 (0.22) 0.77 0.05 (0.03) 0.04 0.04 (0.03) 0.19
Antihypertensive medication use 8.49 (2.09) <0.01 1.44 (0.25) <0.01 0.53 (0.27) <0.05
Diabetes mellitus 5.41 (2.17) 0.01 0.95 (0.26) <0.01 0.79 (0.27) <0.01
Hypercholesterolemia 2.11 (2.08) 0.31 0.71 (0.25) <0.01 0.33 (0.26) 0.20
Smoking history −0.70 (1.98) 0.72 −0.30 (0.24) 0.20 0.16 (0.25) 0.51
Coronary artery disease 3.68 (4.18) 0.38 1.13 (0.51) 0.03 1.38 (0.52) <0.01
LV end-diastolic dimension (per mm) 2.88 (0.20) <0.01 −0.04 (0.03) 0.18 −0.002 (0.03) 0.95
LV mass index (per g/m2) 0.02 (0.01) <0.01 0.02 (0.01) <0.01
Each row is evaluated separately.
Abbreviations: E, early diastolic mitral inflow velocity; e′, early diastolic mitral annular tissue velocity; GLS, global longitudinal strain; B, 
parameter estimate; LV, left ventricular.
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also because elevated BP directly induces pressure-overload, 
which leads to LV hypertrophy with associated intersti-
tial and perivascular fibrosis.33,34 GLS is mainly a measure 
of the contraction of the longitudinally oriented myocar-
dial fibers, which are mostly located in the LV subendo-
cardium. In a hypertensive animal model, the elevation of 
wall stress, accumulation of fibrosis, and myocyte hypertro-
phy were distributed predominantly in the LV subendocar-
dium, and the impairment of GLS occurred in parallel with 
fibrosis in the early stage of hypertensive HF.35 In our study, 
higher ambulatory BP showed a significant association with 
impaired GLS that was independent of LV mass. Therefore, 
we speculate that GLS may be impaired in hypertension 
not only as a result of LV hypertrophy, but also because of 
a direct effect of increased LV afterload, and that ambula-
tory BP measurements may provide more accurate infor-
mation on LV pressure-overload than office BP. Assessing 
BP status by ambulatory monitoring rather than office BP 
may help identify subjects at risk of subclinical LV dys-
function, to whom aggressive treatment could be aimed to 
decrease the likelihood of progression toward clinical sys-
tolic dysfunction.
Our study has several limitations. The cross-sectional 
design does not allow us to detect causal relationships; pro-
spective investigation would be necessary to assess whether 
ambulatory BP values can predict the future development 
of subclinical LV dysfunction. The assessment of relative 
importance of office and ambulatory BP values in the same 
model can be substantially sample-dependent due to multi-
collinearity of ambulatory and office BP. However, the beta 
estimates we presented can be directly interpreted as the 
change that occurs when each of the relevant variables is 
added to the same model. Furthermore, despite being rep-
resentative of the multiethnic community living in northern 
Manhattan, our cohort is predominantly elderly and has a 
high frequency of cardiovascular risk factors; therefore the 
results of the present study might not be directly applicable 
to other populations with different demographics and risk 
factor distribution. Finally, our cohort had a high rate of 
antihypertensive medication use; although antihypertensive 
Table 3. Association of blood pressure measures with LVmass index, E/e′, and GLS
Predictor
Unadjusted Adjusted
LVMI E/e′ GLS LVMIa E/e′b GLSc
Office SBP (per mm Hg) 0.25 (0.06)‡ 0.02 (0.01)† 0.02 (0.01)† 0.09 (0.05) −0.002 (0.007) 0.01 (0.01)
24-hour SBP (per mm Hg) 0.55 (0.07)‡ 0.05 (0.01)‡ 0.05 (0.01)‡ 0.37 (0.06)‡ 0.03 (0.01)† 0.04 (0.01)‡
Daytime SBP (per mm Hg) 0.54 (0.07)‡ 0.05 (0.01)‡ 0.05 (0.01)‡ 0.36 (0.06)‡ 0.03 (0.01)† 0.04 (0.01)‡
Nighttime SBP (per mm Hg) 0.43 (0.06)‡ 0.04 (0.01)‡ 0.04 (0.01)‡ 0.29 (0.05)‡ 0.02 (0.01)† 0.03 (0.01)†
SBP night-to-day ratio (per %) 17.7 (13.5) 4.54 (1.61)† 1.52 (1.70) 6.73 (11.3) 0.56 (1.53) −0.50 (1.70)
Daytime SBP variability (per mm Hg) 0.89 (0.30)† 0.14 (0.04)‡ 0.09 (0.04)* 0.44 (0.26) 0.01 (0.04) 0.04 (0.04)
Daytime SBP variability (per mm Hg)d 0.05 (0.26) −0.01 (0.04) −0.001 (0.04)
Nighttime SBP variability (per mm Hg) 0.75 (0.30)* 0.09 (0.04)* 0.12 (0.04)† 0.30 (0.25) 0.01 (0.03) 0.09 (0.04)*
Nighttime SBP variability (per mm Hg)d −0.01 (0.25) −0.01 (0.04) 0.07 (0.04)
Office DBP (per mm Hg) 0.06 (0.11) −0.01 (0.01) 0.04 (0.01)† 0.08 (0.09) −0.02 (0.01) 0.04 (0.01)†
24-hour DBP (per mm Hg) 0.39 (0.12)† −0.02 (0.01) 0.08 (0.01)‡ 0.53 (0.10)‡ −0.004 (0.01) 0.08 (0.02)‡
Daytime DBP (per mm Hg) 0.36 (0.11)† −0.03 (0.01)* 0.07 (0.01)‡ 0.52 (0.10)‡ −0.01 (0.01) 0.08 (0.01)‡
Nighttime DBP (per mm Hg) 0.31 (0.11)† 0.01 (0.01) 0.06 (0.01)‡ 0.35 (0.09)‡ 0.01 (0.01) 0.06 (0.01)‡
DBP Night-to-day ratio (per %) 2.43 (12.0) 5.02 (1.44)† 1.08 (1.51) −7.84 (10.1) 2.48 (1.36) −0.24 (1.52)
Daytime DBP variability (per mm Hg) 1.09 (0.43)* 0.03 (0.05) 0.17 (0.05)† 0.94 (0.36)† −0.07 (0.05) 0.14 (0.05)*
Daytime DBP variability (per mm Hg)d 0.63 (0.36) −0.07 (0.05) 0.09 (0.05)
Nighttime DBP variability (per mm Hg) −0.18 (0.42) −0.06 (0.05) 0.04 (0.05) −0.35 (0.34) −0.06 (0.05) 0.04 (0.05)
Nighttime DBP variability (per mm Hg)d −0.49 (0.34) −0.06 (0.05) 0.01 (0.05)
Non-dipping patterne 0.0005 (2.02) 0.70 (0.24) † 0.17 (0.25) −1.88 (1.68) 0.27 (0.23) 0.001 (0.25)
Values are parameter estimates (B) and SE. Each predictor is evaluated in a separate model. *P < 0.05, †P < 0.01, ‡P < 0.001.
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; LVMI, left ventricular mass index; E, early diastolic mitral inflow 
velocity; e′, early diastolic mitral annular tissue velocity; GLS, global longitudinal strain.
aAdjusted for age, sex, race/ethnicity, diabetes mellitus, LV end-diastolic dimension, and antihypertensive medication use.
bAdjusted for age, sex, race/ethnicity, body mass index, diabetes mellitus, hypercholesterolemia, coronary artery disease, LV end-diastolic 
dimension, LV mass index, and antihypertensive medication use.
cAdjusted for age, sex, race/ethnicity, body mass index, diabetes mellitus, coronary artery disease, LV mass index, and antihypertensive 
medication use.
dIn addition to the general adjustments, data were further adjusted for the corresponding mean ambulatory BP value.
eDefined as SBP night-to-day ratio >0.9.
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treatment was adjusted for in the multivariable analyses, 
the results may not be directly applicable to a normotensive 
cohort.
In conclusion, in our community-based, predomi-
nantly elderly cohort, higher ambulatory BP was sig-
nificantly associated with impaired GLS in subjects 
with normal LVEF, independently of cardiovascular 
risk factors. Moreover, the association of ambulatory 
BP with impaired GLS was stronger than office BP val-
ues. Ambulatory BP monitoring might have a role in the 
risk stratification of hypertensive patients for early LV 
dysfunction.
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